Management of aortic dilatation in Marfan syndrome associated with lung fibrosis
DOI:
https://doi.org/10.18203/2349-3291.ijcp20250774Keywords:
Marfan syndrome, Fibrillin-1 gene, Lung fibrosis, Interstitial lung disease, Aortic root dilatation, PaediatricAbstract
Marfan syndrome (MFS) is an autosomal dominant disorder caused by the mutation in the fibrillin-1 (FBN-1) on chromosome 15q21. The predominant clinical manifestations mainly in ocular, cardiovascular and skeletal system. MFS can also lead to deterioration of lungs progressively over time. In case of lung fibrosis or may be spontaneous in case of spontaneous pneumothorax. Physical examination of this patient revealed the following significant phenotypic manifestations of MFS like scoliosis and skin triae, wrist sign, displaced nasal septum, myopic astigmatism of both eyes pectus carinatum. Furthermore; the computed tomography (CT) scan depicted the fibrotic changes in the lung parenchyma and the echocardiogram depicted the dilation of the aortic root, mitral regurgitation, tricuspid regurgitation. Both X-ray and CT results revealed bilateral lung fibrosis. And the patient was monitored by performing spirometry tests series annually, to detect the evaluation of the prognosis of the patients’ condition. According to the latest publications in MS with interstitial lung disease, this article further reveals the necessity of taking into account the diagnosis of pulmonary manifestations in MS patients with vascular complications. This case illustrates the importance of reviewing the timely management of aortic root dilatation in MFS with lung fibrosis.
Metrics
References
Salik I, Rawla P. Marfan Syndrome. Treasure Island (FL): StatPearls Publishing. 2023.
Feather A, Randall D, Waterhouse M. Kumar and Clark’s Clinical Medicine. 10th Edition. Elsevier Science Health Science. 2020.
Tun MH, Borg B, Godfrey M, Hadley-Miller N, Chan ED. Respiratory manifestations of Marfan syndrome: a narrative review. J Thorac Dis. 2021;13(10):6012-25. DOI: https://doi.org/10.21037/jtd-21-1064
Dyhdalo K, Farver C. Pulmonary histologic changes in Marfan syndrome: a case series and literature review. Am J Clin Pathol. 2011;136(6):857-63. DOI: https://doi.org/10.1309/AJCP79SNDHGKQFIN
The Marfan Foundation. Marfan Syndrome - Marfan Foundation. 2022. Available at: https://marfan.org/ conditions/marfan-syndrome/. Accessed on 12 January 2024.
Ramirez F, Dietz HC. Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev. 2007;17(3):252-8. DOI: https://doi.org/10.1016/j.gde.2007.04.006
Wood JR, Bellamy D, Child AH, Citron KM. Pulmonary disease in patients with Marfan syndrome. Thorax. 1984;39(10):780-4. DOI: https://doi.org/10.1136/thx.39.10.780
Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet. 2004;36(8):855-60. DOI: https://doi.org/10.1038/ng1392
Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476-85. DOI: https://doi.org/10.1136/jmg.2009.072785
Stark VC, Arndt F, Harring G, von Kodolitsch Y, Kozlik-Feldmann R, Mueller GC, et al. Kid-Short Marfan Score (Kid-SMS) Is a Useful Diagnostic Tool for Stratifying the Pre-Test Probability of Marfan Syndrome in Childhood. Diseases. 2015;3(1):24-33. DOI: https://doi.org/10.3390/diseases3010024
Isselbacher EM, Bonaca MP, Di Eusanio M, Froehlich J, Bossone E, Sechtem U, et al; International Registry of Aortic Dissection (IRAD) Investigators. Recurrent Aortic Dissection: Observations From the International Registry of Aortic Dissection. Circulation. 2016;134(14):1013-24. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.019359
Erbel R, Eggebrecht H. Aortic dimensions and the risk of dissection. Heart. 2006;92:137-42. DOI: https://doi.org/10.1136/hrt.2004.055111
Treasure T, Austin C, Kenny LA, Pepper J. Personalised external aortic root support in aneurysm disease. Curr Opin Cardiol. 2022;37:454-8. DOI: https://doi.org/10.1097/HCO.0000000000000990
Singh MN, Lacro RV. Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications. Can J Cardiol. 2016;32(1):66-77. DOI: https://doi.org/10.1016/j.cjca.2015.11.003
The Marfan Foundation. Bones and joints in Marfan Syndrome - Marfan Foundation. 2021. Available at: https://marfan.org/resource-library/bones-and-joints -in-marfan-syndrome/. Accessed on 12 January 2024.
The Marfan Foundation. The Eyes in Marfan Syndrome - Marfan Foundation. 2021. Available at: https://marfan.org/resource-library/the-eyes-in-marfan-syndrome/. Accessed on 12 January 2024.
Loeys B, Nuytinck L, Delvaux I, De Bie S, De Paepe A. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med. 2001;161(20):2447-54. DOI: https://doi.org/10.1001/archinte.161.20.2447
Koo HK, Lawrence KA, Musini VM. Beta-blockers for preventing aortic dissection in Marfan syndrome. Cochrane Database Syst Rev. 2017;11(11):CD011103. DOI: https://doi.org/10.1002/14651858.CD011103.pub2
Igondjo-Tchen S, Pagès N, Bac P, Godeau G, Durlach J. Marfan syndrome, magnesium status and medical prevention of cardiovascular complications by hemodynamic treatments and antisense gene therapy. Magnes Res. 2003;16(1):59-64.
Scripps Research. How a new drug prototype regenerates lung tissue. Available at: https://www. scripps.edu/news-and-events/press-room/2024/ 20240410-schultz-bollong-lung-regeneration.html. Accessed on 12 January 2024.